Bioavailability study of fexofenadine HCl new formulation tablet

Trial Identifier:	BDR17987
Sponsor:	Opella Healthcare Group SAS, a Sanofi Company
Start Date:	February 2024
Primary Completion Date:	May 2024
Study Completion Date:	May 2024
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Canada, Quebec	Quebec, Canada, G1P 0A2

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.